Pantoc (Pantoprazole)

Pantoprazole, the active ingredient in Pantoc, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to manage gastro‑intestinal reflux disease and related conditions in adults.

GNH USA supplies Pantoc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. It is indicated for several gastrointestinal disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing and reduces symptom recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Peptic ulcer disease prevention: lowers ulcer risk when used with NSAIDs or in high‑risk patients. - Helicobacter pylori eradication regimens: serves as a component of triple‑therapy protocols to improve eradication rates.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence: excess gas. - Constipation: occasional.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile‑associated colitis: persistent diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: hepatitis‑like picture. - Acute interstitial nephritis: kidney inflammation.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Renal impairment: dose adjustment may be required in severe kidney disease. - Hepatic impairment: monitor liver function in patients with liver disease. - Long‑term therapy: assess need for periodic review to avoid bone‑density loss. - Drug interactions: review concomitant medications that affect gastric pH or CYP enzymes. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): markedly decreased plasma levels. - Clopidogrel: diminished antiplatelet effect, consider alternative therapy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate: reduced renal clearance, watch for toxicity. - Digoxin: slight increase in serum concentration, check levels if clinically indicated.